Dr. Mark D'Esposito

I mean, that's how the pharmaceutical company works.

SSRIs, too.

Yeah.

I mean, it works, so let's do it.

I'm all for that as a physician.

But if I had my choice, you know, drugs that boost up multiple cysts, all the catecholamines, the ones that boost up dopamine, epinephrine and norepinephrine, I would steer away from those because you have no control

over how you're modulating the system.

Again, I was sort of talking about a cocktail.

It may be a little bit of dopamine and a little more norepinephrine, but if you take something like Ritalin Adderall, you're just getting the same amount.

So it's kind of, if I was to start to sort of experiment, then I wouldn't use Adderall or Ritalin as the drug that I think would help, even though they're clinically sort of useful.

I use things like bromocriptine and guanfacine where they

can modulate a very specific drug.

And then, and then, yeah, then the goal is to, to optimize.

And that's what we're trying to do with cognitive therapy and everything's sleeping better and better nutrition.

All of these are aiming to optimize, not, you know, reach some super human potential.

Yeah, it's hard to know.

I mean, I think certain drugs just improve general abilities.

Either they speed how fast you can process it or how efficient you can process or narrow the focus of your attention, and that just helps all abilities.

So it's hard to say.

I think there just has to be more work on really understanding what specifically –